Ressler, Julia Maria https://orcid.org/0000-0001-8602-0878
Plaschka, Maud https://orcid.org/0000-0003-1137-7623
Silmbrod, Rita https://orcid.org/0009-0005-2506-9893
Bachmayr, Victoria https://orcid.org/0000-0002-4585-1736
Shaw, Lisa Ellen https://orcid.org/0000-0003-2273-7655
Silly, Thomas
Zila, Nina https://orcid.org/0000-0003-1193-1014
Stepan, Andreas
Kusienicka, Anna https://orcid.org/0000-0003-0933-2610
Tschandl, Philipp https://orcid.org/0000-0003-0391-7810
Tittes, Julia https://orcid.org/0000-0003-0844-3626
Roka, Florian
Haslik, Werner
Petzelbauer, Peter https://orcid.org/0000-0001-7080-5259
Koenig, Franz
Kunstfeld, Rainer
Farlik, Matthias https://orcid.org/0000-0003-0698-2992
Halbritter, Florian https://orcid.org/0000-0003-2452-4784
Weninger, Wolfgang
Hoeller, Christoph https://orcid.org/0000-0003-1192-0227
Funding for this research was provided by:
“Clinician Scientist Research Fellowship" by the ÖGDV, the Austrian Society of Dermatology and Venereology
Amgen Limited
Article History
Received: 18 July 2023
Accepted: 13 November 2024
First Online: 16 January 2025
Competing interests
: J.M.R. received speaker honoraria from Bristol-Myers Squibb, Roche, Amgen and Novartis and travel support by Sanofi, Roche and Bristol-Myers Squibb through the institution. P.T. received honoraria from Silverchair, unrestricted grants for education projects from Lilly, and honoraria for lectures from AbbVie, Lilly, FotoFinder and Novartis. J.T. reports an unrestricted grant from Lilly, consulting fees from Lilly, speaker honoraria from Lilly and Novartis, all outside the submitted work, as well as travel support from Almirall, AbbVie and Bristol-Myers Squibb through institution. C.H. reports speaker honoraria from Amgen, BMS, MSD, Novartis, Roche, participation in advisory Boards: Amgen, Astra Zeneca, BMS, Incyte, MSD, Novartis, Pierre Fabre, Roche and research funding by Amgen to the institution. The other authors declare no competing interests.